Mark L. Day
Impact in
- Behavioral Neuroscience top 1%
- Stress Responses and Cortisol
-
- Neuroscience and Neuropharmacology Research
Papers in
-
- Cancer-related gene regulation 9
- Wnt/β-catenin signaling in development and cancer 9
- Epigenetics and DNA Methylation 8
- Oncology 29
- HER2/EGFR in Cancer Research 11
- Cancer-related Molecular Pathways 8
- Co-authors
- Kathleen C. Day (29 shared papers)Michael T. McCabe (8 shared papers)Richard Morris (4 shared papers)Mark A. Rubin (9 shared papers)Abdo J. Najy (3 shared papers)Rainer Kuefer (8 shared papers)Harris Perlman (1 shared paper)Anthony J. Raffo (1 shared paper)
- Journals
- Journal of Biological Chemistry (11 papers)Cancer Research (8 papers)Oncogene (5 papers)Journal of Pharmacology and Experimental Therapeutics (5 papers)PLoS ONE (4 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mark L. Day
115 papers receiving 6.5k citations
Mark L. Day's Hit Papers
Peers
Comparison fields: 5 of 138
- Behavioral Neuroscience 384
- Cellular and Molecular Neuroscience 1.2k
- Developmental Neuroscience 212
- Immunology and Allergy 271
- Biological Psychiatry 104
Countries citing papers authored by Mark L. Day
This map shows the geographic impact of Mark L. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Day more than expected).
Fields of papers citing papers by Mark L. Day
This network shows the impact of papers produced by Mark L. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Day. The network helps show where Mark L. Day may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark L. Day, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. | 1995 | 451 |
| 2 | 2008 | 413 | |
| 3 | Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory Hit paper breakdown → | 2003 | 387 |
| 4 | Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. | 1995 | 274 |
| 5 | 2003 | 204 | |
| 6 | 2008 | 204 | |
| 7 | 2008 | 155 | |
| 8 | 2008 | 154 | |
| 9 | 2007 | 149 | |
| 10 | 2003 | 148 | |
| 11 | 2016 | 148 | |
| 12 | 2001 | 143 | |
| 13 | 2005 | 137 | |
| 14 | 1999 | 128 | |
| 15 | 1987 | 126 | |
| 16 | 2006 | 113 | |
| 17 | 1997 | 102 | |
| 18 | 1999 | 100 | |
| 19 | 2006 | 97 | |
| 20 | 2014 | 95 |
About Mark L. Day
Mark L. Day is a scholar working on Molecular Biology, Oncology, Cellular and Molecular Neuroscience, Surgery and Pulmonary and Respiratory Medicine, having authored 117 papers that have together received 6.6k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (17 papers), HER2/EGFR in Cancer Research (11 papers), Prostate Cancer Treatment and Research (11 papers), Bladder and Urothelial Cancer Treatments (11 papers), Cancer-related gene regulation (9 papers), Wnt/β-catenin signaling in development and cancer (9 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related Molecular Pathways (8 papers). The work is most often cited by research in Behavioral Neuroscience (384 citations), Cellular and Molecular Neuroscience (1.2k citations), Developmental Neuroscience (212 citations), Immunology and Allergy (271 citations) and Biological Psychiatry (104 citations). Mark L. Day has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Kathleen C. Day, Michael T. McCabe, Richard Morris, Mark A. Rubin, Abdo J. Najy, Rainer Kuefer, Harris Perlman, Anthony J. Raffo, Min‐Wei Chen and Ralph Buttyan. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Oncogene, Journal of Pharmacology and Experimental Therapeutics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.